Boardroom Alpha
Boardroom Alpha
DOC · Additional Proxy Materials (DEFA14A) · Filed March 12, 2026

Healthpeak Properties Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
March 12, 2026
Ticker
DOC
Accession
0001104659-26-027100
Boardroom Alpha · Filing insights

Healthpeak's proxy seeks election of nine directors, advisory executive compensation approval, and Deloitte audit ratification; board backs all.

About Healthpeak Properties Inc
Market cap
$13.4B
1Y TSR
+17.7%
3Y TSR
+4.2%
Board grade
C
Sector
Real Estate
CEO
Scott M Brinker
Last annual meeting: Apr 30, 2026 · View full Healthpeak Properties Inc profile →
HEALTHPEAK PROPERTIES, INC.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

PROXY STATEMENT PURSUANT TO SECTION 14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No.     )

  Filed by the Registrant

  Filed by a Party other than the Registrant

Check the appropriate box:

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material under §240.14a-12

HEALTHPEAK PROPERTIES, INC.

Graphic

(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

No fee required.

Fee paid previously with preliminary materials.

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.

GRAPHIC

Your Vote Counts! *Please check the meeting materials for any special requirements for meeting attendance. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V84633-P44874 HEALTHPEAK PROPERTIES, INC. 4600 SOUTH SYRACUSE STREET SUITE 500 DENVER, CO 80237 2026 Annual Meeting Vote by April 29, 2026 11:59 PM ET HEALTHPEAK PROPERTIES, INC. Virtually at: www.virtualshareholdermeeting.com/DOC2026 You invested in HEALTHPEAK PROPERTIES, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on April 30, 2026. Vote Virtually at the Meeting* April 30, 2026 10:00 a.m. Mountain Time Get informed before you vote View the Notice, 2026 Proxy Statement and the 2025 Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 16, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

GRAPHIC

Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. Voting Items Board Recommends V84634-P44874 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. 1. Election of Directors Nominees: 1a. Scott M. Brinker For 1b. Katherine M. Sandstrom For 1c. John T. Thomas For 1d. Brian G. Cartwright For 1e. James B. Connor For 1f. R. Kent Griffin, Jr. For 1g. Sara G. Lewis For 1h. Ava E. Lias-Booker For 1i. Richard A. Weiss For 2. Approval of 2025 executive compensation on an advisory basis. For 3. Ratification of the appointment of Deloitte & Touche LLP as Healthpeak Properties, Inc.’s independent registered public accounting firm for the year ending December 31, 2026. For NOTE: At their discretion, the named proxies are authorized to consider and vote upon such other business as may properly come before the meeting or any adjournments or postponements thereof.

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Healthpeak Properties Inc (DOC)

Reference

Frequently asked questions

When did Healthpeak Properties Inc file this DEFA14A?
Healthpeak Properties Inc (DOC) filed this Additional Proxy Materials (DEFA14A) with the SEC on March 12, 2026. The accession number assigned by EDGAR is 0001104659-26-027100.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Healthpeak's proxy seeks election of nine directors, advisory executive compensation approval, and Deloitte audit ratification; board backs all. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Healthpeak Properties Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Healthpeak Properties Inc has filed under CIK 765880, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer